
Despite recent changes in corporate tax law, Ireland remains a valuable and attractive partner in the development and manufacture of biopharmaceuticals.
Rory Mullen is the West Coast director and senior vice president of IDA Ireland. For more information, email [email protected].

Despite recent changes in corporate tax law, Ireland remains a valuable and attractive partner in the development and manufacture of biopharmaceuticals.

November 25th 2014